Novo CEO pressed by Senate to chop costs of obesity, diabetes medicines CEO Lars Fruergaard Jørgensen instructed lawmakers the organization would contemplate new talks with insurers with regards to the record rates of Wegovy and Ozempic whenever they pledge to help keep the medicines on their formularies. Expenditure in electronic https://kethek.com/